RT Book, Section
A1 Feldman, Darren R.
A1 Bosl, George J.
A2 Boyiadzis, Michael M.
A2 Frame, James N.
A2 Kohler, David R.
A2 Fojo, Tito
SR Print(0)
ID 1128366747
T1 Testicular Cancer
T2 Hematology-Oncology Therapy, 2e
YR 2016
FD 2016
PB McGraw-Hill Education
PP New York, NY
SN 9780071637893
LK hemonc.mhmedical.com/content.aspx?aid=1128366747
RD 2024/04/19
AB EpidemiologyTable  Graphic  Jump  Location|Download  (.pdf)|PrintIncidence:8,820  estimated  new  cases  for  2014  in  the  United  States5.5  per  100,000  males  per  yearDeaths:Estimated  380  in  2014Median  age:33  yearsSiegel  R  et  al.  CA  Cancer  J  Clin  2013;63:11–30Surveillance,  Epidemiology  and  End  Results  (SEER)  Program,  available  from  http://seer.cancer.gov  (accessed  in  2013)Table  Graphic  Jump  Location|Download  (.pdf)|PrintEpidemiologyFrequency  of  Stage  at  Presentation  SeminomaNonseminomaStage  I85%60%Stage  II10%20%Stage  III5%20%Frequency  of  IGCCCG  Risk  Groups  at  Diagnosis  for  Patients  Requiring  ChemotherapyIGCCCG  Risk  GroupSeminomaNonseminomaAllGood90%56%60%Intermediate10%28%26%PoorN/A16%14%IGCCCG,  International  Germ  Cell  Cancer  Collaborative  Group;  GCT  germ  cell  tumorBiggs  M,  Schwartz  S.  “Cancer  of  the  Testis.”  In  Ries  SEER  Survival  Monograph:  Cancer  Survival  Among  Adults:  U.S.  SEER  Program,  1988–2001.  2007:165–170Bosl  G  et  al.  In  Devita  V,  Lawrence  T,  Rosenberg  S,  eds.  Cancer:  Principles  and  Practice  of  Oncology.  Philadelphia:  Lippincott  Williams  and  Wilkins,  2008:1463–1485International  Germ  Cell  Cancer  Collaborative  Group  (IGCCCG).  J  Clin  Oncol  1997;15:594–603Siegel  R  et  al.  CA  Cancer  J  Clin  2014;64:9–29